BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3036333)

  • 1. Selecting initial therapy. Seminoma and nonseminoma.
    Donohue JP
    Cancer; 1987 Aug; 60(3 Suppl):490-5. PubMed ID: 3036333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
    Dash A; Carver BS; Stasi J; Bajorin DF; Motzer RJ; Bosl GJ; Sheinfeld J
    Cancer; 2008 Feb; 112(4):800-5. PubMed ID: 18172902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Stage II Germ Cell Tumors.
    Ghandour RA; Singla N; Bagrodia A
    Urol Clin North Am; 2019 Aug; 46(3):363-376. PubMed ID: 31277731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary management of postchemotherapy testis cancer.
    Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
    Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy.
    Heidenreich A; Pfister D
    Arch Esp Urol; 2012 Mar; 65(2):215-26. PubMed ID: 22414450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of stage I testicular germ cell tumours.
    Chovanec M; Hanna N; Cary KC; Einhorn L; Albany C
    Nat Rev Urol; 2016 Nov; 13(11):663-673. PubMed ID: 27618772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral laparoscopic postchemotherapy retroperitoneal lymph-node dissection in nonseminomatous germ cell tumors--a comparison to template dissection.
    Aufderklamm S; Todenhöfer T; Hennenlotter J; Gakis G; Mischinger J; Mundhenk J; Germann M; Stenzl A; Schwentner C
    J Endourol; 2013 Jul; 27(7):856-61. PubMed ID: 23516988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer.
    Stephenson AJ; Bosl GJ; Motzer RJ; Bajorin DF; Stasi JP; Sheinfeld J
    J Clin Oncol; 2007 Dec; 25(35):5597-602. PubMed ID: 18065732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-surgical treatment of testicular cancer: guidelines for the urologist].
    Páez Borda A; Llorente Abarca C; Herrero Payo A; Acebal Lucia J; Berenguer Sánchez A
    Actas Urol Esp; 1993 Apr; 17(4):226-33. PubMed ID: 8393610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The case for relevant staging of germ cell tumors.
    Logothetis CJ
    Cancer; 1990 Feb; 65(3 Suppl):709-17. PubMed ID: 2154316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of subdiaphragmatic lymph node metastases of primary testicular seminoma (stage II)].
    Gardani G; Lattuada A; Valvo F
    Radiol Med; 1989; 77(1-2):104-14. PubMed ID: 2928559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
    Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
    J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary chemotherapy for clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patients.
    Logothetis CJ; Swanson DA; Dexeus F; Chong C; Ogden S; Ayala AG; von Eschenbach AC; Johnson DE; Samuels ML
    J Clin Oncol; 1987 Jun; 5(6):906-11. PubMed ID: 2438389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term results of laparoscopic retroperitoneal lymph node dissection (RPLND) in low-stage nonseminomatous germ-cell testicular tumors (NSGCTT) performed by a senior surgeon: 1999-2003].
    Pizzocaro G; Schiavo M; Solima S; Vitellaro M; Biasoni N; Nicolai N
    Urologia; 2010; 77 Suppl 17():50-6. PubMed ID: 21308676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeat retroperitoneal lymph-node dissection after chemotherapy for metastatic testicular germ cell tumour.
    Willis SF; Winkler M; Savage P; Seckl MJ; Christmas TJ
    BJU Int; 2007 Oct; 100(4):809-12. PubMed ID: 17711512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A clinical study of testicular tumors].
    Matsuki H; Ozono S; Arai K; Saka M; Cho M; Nakagawa Y; Kaneko Y; Yoshida K; Okamoto S; Maruyama Y
    Hinyokika Kiyo; 1988 Oct; 34(10):1757-65. PubMed ID: 2854363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of localized germ-cell tumours of the testis].
    Loriot Y; Fizazi K
    Rev Prat; 2007 Feb; 57(4):379-84. PubMed ID: 17455739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.